May 20, 2020
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
May 20, 2020
China Biologic Reports Financial Results for the First Quarter of 2020
May 12, 2020
China Biologic Products to Report First Quarter 2020 Financial Results
Mar 03, 2020
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results
Feb 14, 2020
China Blood Products Market Outlook, 2020 to 2026 - Industry Integration Speeds Up, Concentration Rises Further
Nov 04, 2019
China Biologic Products to Report Third Quarter 2019 Financial Results
Oct 17, 2019
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
Sep 24, 2019
China Biologic Forms Special Committee to Review "Going Private" Proposal
Sep 18, 2019
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
Jul 26, 2019
China Biologic Products to Report Second Quarter 2019 Financial Results
Apr 30, 2019
China Biologic Products to Report First Quarter 2019 Financial Results
Dec 14, 2018
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
Aug 28, 2018
China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman
Aug 24, 2018
China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement
Aug 13, 2018
China Biologic Names Bing Li as New CEO
Jul 27, 2018
China Biologic Products to Report Second Quarter 2018 Financial Results
Jun 11, 2018
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant
Apr 24, 2018
China Biologic to Report First Quarter of 2018 Financial Results
Feb 23, 2018
China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results
Feb 14, 2018
China Biologic to Build New Collection Station in Hainan Province